Table 2 |
|||||
|
Antibodies against 'liver specific' antigens in sera with AMA-like and UD ctp IIF |
|||||
|
Patients |
n (%) |
Sp100 |
LKM1 |
SLA |
LC1 |
|
|
|||||
|
AMA (n = 42) |
|||||
|
Connective tissue diseases |
25/42(60%) |
3 |
8 |
0 |
1 |
|
Rheumatoid arthritis |
6/42 (14%) |
0 |
5 |
0 |
0 |
|
Other |
11/42 (26%) |
1 |
6 |
0 |
0 |
|
Unidentified (n = 33) |
|||||
|
Connective tissue diseases |
15/33 (46%) |
3 |
6 |
2 |
0 |
|
Rheumatoid arthritis |
6/33 (18%) |
0 |
2 |
0 |
0 |
|
Other |
12/33 (36%) |
1 |
6 |
0 |
0 |
|
|
|||||
|
Rotar et al. Arthritis Research & Therapy 2005 7(Suppl 1):P2 doi:10.1186/ar1523 |
|||||